Last reviewed · How we verify

STUDY00015328: Sepsis Endotypes

NCT03146546 ENROLLING_BY_INVITATION

Determine the utility of biomarkers measured in blood and body fluid (stool, saliva, tracheal aspirate) when combined with clinical data, for predicting sepsis phenotypes that are associated with poor clinical outcomes. We hypothesize that resistin is a biomarker which provides critical prognostic information when used in conjunction with standard clinical data, in patients with sepsis and septic shock.

Details

Lead sponsorMilton S. Hershey Medical Center
StatusENROLLING_BY_INVITATION
Enrolment200
Start dateThu Aug 06 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
CompletionTue Jun 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Countries

United States